These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29530714)

  • 121. Improvement of the agitation granulation method to prepare granules containing a high content of a very hygroscopic drug.
    Hirai N; Ishikawa K; Takahashi K
    J Pharm Pharmacol; 2006 Nov; 58(11):1437-41. PubMed ID: 17132205
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Application of SeDeM expert systems in preformulation studies of pediatric ibuprofen ODT tablets.
    Sipos E; Oltean AR; Szabó ZI; Rédai EM; Nagy GD
    Acta Pharm; 2017 Jun; 67(2):237-246. PubMed ID: 28590910
    [TBL] [Abstract][Full Text] [Related]  

  • 123. New nano-matrix oral formulation of nanoprecipitated cyclosporine A prepared with multi-inlet vortex mixer.
    Suzuki H; Hamao S; Seto Y; Sato H; Wong J; Prud'homme RK; Chan HK; Onoue S
    Int J Pharm; 2017 Jan; 516(1-2):116-119. PubMed ID: 27845213
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Development of a solid dosage platform for the oral delivery of bilayer vesicles.
    Wilkhu JS; McNeil SE; Anderson DE; Kirchmeier M; Perrie Y
    Eur J Pharm Sci; 2017 Oct; 108():71-77. PubMed ID: 28619620
    [TBL] [Abstract][Full Text] [Related]  

  • 125. A Novel Lactose/MCC/L-HPC Triple-Based Co-Processed Excipients with Improved Tableting Performance Designed for Metoclopramide Orally Disintegrating Tablets.
    Dai X; Wang J; Yan B; Wang Q; Shen Y; Chen Y; Tian Y
    Pharmaceutics; 2024 Jul; 16(7):. PubMed ID: 39065656
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Development of the Modified Ocimum gratissimum Seeds for Orally Disintegrating Tablets.
    Dang YNT; Tran PHL; Tran TTD
    Recent Pat Drug Deliv Formul; 2020; 14(1):40-47. PubMed ID: 31660821
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Characterization of the buccal and gastric transit of orally disintegrating tablets in humans using gamma scintigraphy.
    Kambayashi A; Sako K; Kondo H
    Int J Pharm; 2020 Feb; 576():118937. PubMed ID: 31816352
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Preparation and Characterization of Co-Processed Mannitol and Sorbitol Using NanoCrySP Technology.
    Rao SG; Parmar PK; Reddy KV; Bansal AK
    AAPS PharmSciTech; 2021 Jul; 22(5):201. PubMed ID: 34231193
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Clinical disintegration time of orally disintegrating tablets clinically available in Japan in healthy volunteers.
    Yoshita T; Uchida S; Namiki N
    Biol Pharm Bull; 2013; 36(9):1488-93. PubMed ID: 23995661
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Investigation of Formulation and Process of Lyophilised Orally Disintegrating Tablet (ODT) Using Novel Amino Acid Combination.
    AlHusban F; ElShaer AM; Kansara JH; Smith AM; Grover LM; Perrie Y; Mohammed AR
    Pharmaceutics; 2010 Jan; 2(1):1-17. PubMed ID: 27721339
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Fast disintegrating crystalline solid dispersions of simvastatin for incorporation into orodispersible tablets.
    Pabari RM; Jamil A; Kelly JG; Ramtoola Z
    Int J Pharm Investig; 2014 Apr; 4(2):51-9. PubMed ID: 25006549
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Pore structure and surface area of mannitol powder, granules and tablets determined with mercury porosimetry and nitrogen adsorption.
    Westermarck S; Juppo AM; Kervinen L; Yliruusi J
    Eur J Pharm Biopharm; 1998 Jul; 46(1):61-8. PubMed ID: 9700023
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Preparation and optimization of fast disintegrating tablets of isosorbide dinitrate using lyophilization method for oral drug delivery.
    Alami-Milani M; Salatin S; Nasiri E; Jelvehgari M
    Ther Deliv; 2021 Jul; 12(7):523-538. PubMed ID: 34098729
    [No Abstract]   [Full Text] [Related]  

  • 134. Pharmacotechnical Evaluation by SeDeM Expert System to Develop Orodispersible Tablets.
    Rao MRP; Sapate S; Sonawane A
    AAPS PharmSciTech; 2022 May; 23(5):133. PubMed ID: 35534652
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Fast disintegrating tablets: Opportunity in drug delivery system.
    Parkash V; Maan S; Deepika ; Yadav SK; Hemlata ; Jogpal V
    J Adv Pharm Technol Res; 2011 Oct; 2(4):223-35. PubMed ID: 22247889
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Formulation design for orally disintegrating tablets containing enteric-coated particles.
    Okuda Y; Okamoto Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Chem Pharm Bull (Tokyo); 2014; 62(5):407-14. PubMed ID: 24789923
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Spray-dried chitosan as a direct compression tableting excipient.
    Chinta DD; Graves RA; Pamujula S; Praetorius N; Bostanian LA; Mandal TK
    Drug Dev Ind Pharm; 2009 Jan; 35(1):43-8. PubMed ID: 18622875
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Isolation of Itraconazole Nanostructured Microparticles via Spray Drying with Rational Selection of Optimum Base for Successful Reconstitution and Compaction.
    McComiskey KPM; McDonagh A; Tajber L
    AAPS PharmSciTech; 2019 Jun; 20(5):217. PubMed ID: 31172323
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Evaluation of disintegration properties of orally rapidly disintegrating tablets using a novel disintegration tester.
    Kondo K; Niwa T; Danjo K
    Chem Pharm Bull (Tokyo); 2012; 60(10):1240-8. PubMed ID: 23036967
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Development of a new disintegration method for orally disintegrating tablets.
    Kakutani R; Muro H; Makino T
    Chem Pharm Bull (Tokyo); 2010 Jul; 58(7):885-90. PubMed ID: 20606331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.